Brind.
  1. Assembly Biosciences is developing therapeutics aimed at treating serious viral diseases, including Herpes Simplex Virus.

Assembly Biosciences received clearance for study expansion.

1 report, 1 independent Updated Aug 7
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Assembly Biosciences received clearance for study expansion.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswireAssembly Biosciences Reports Second Quarter 2025 Financial Results and Recent Updates – On track for proof-of-concept Phase 1b data no later than this fall in participants with recurrent genital herp